News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
21,000 Results
Type
Article (2101)
Company Profile (15)
Press Release (18884)
Multimedia
Podcasts (8)
Webinars (1)
Section
Business (5963)
Career Advice (62)
Deals (810)
Drug Delivery (1)
Drug Development (3286)
Employer Resources (3)
FDA (599)
Job Trends (761)
News (10321)
Policy (733)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
Academia (276)
Accelerated approval (2)
Adcomms (3)
Allergies (1)
Alliances (1741)
ALS (26)
Alzheimer's disease (354)
Antibody-drug conjugate (ADC) (17)
Approvals (615)
Artificial intelligence (37)
Autoimmune disease (10)
Automation (3)
Bankruptcy (6)
Best Places to Work (736)
Biosimilars (5)
Biotechnology (11)
Brain cancer (6)
Breast cancer (1)
Cancer (88)
Cardiovascular disease (5)
Career advice (50)
Career pathing (2)
CAR-T (5)
CDC (2)
Cell therapy (16)
Cervical cancer (3)
Clinical research (2745)
Collaboration (107)
Compensation (33)
Complete response letters (1)
COVID-19 (44)
CRISPR (1)
C-suite (67)
Data (327)
Denatured (1)
Depression (67)
Diabetes (4)
Diagnostics (83)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (3)
Duchenne muscular dystrophy (8)
Earnings (1526)
Editorial (5)
Employer branding (1)
Employer resources (3)
Events (3039)
Executive appointments (81)
FDA (740)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (89)
Gene editing (1)
Gene therapy (26)
GLP-1 (33)
Government (80)
Guidances (31)
Healthcare (575)
Huntington's disease (8)
IgA nephropathy (6)
Immunology and inflammation (21)
Immuno-oncology (3)
Indications (6)
Infectious disease (45)
Inflammatory bowel disease (12)
Inflation Reduction Act (1)
Intellectual property (7)
Interviews (12)
IPO (306)
IRA (1)
Job creations (92)
Job search strategy (45)
JPM (14)
Layoffs (26)
Leadership (1)
Legal (94)
Liver cancer (1)
Longevity (3)
Lung cancer (10)
Lymphoma (9)
Machine learning (1)
Management (1)
Manufacturing (25)
Medical device (264)
Medtech (268)
Mergers & acquisitions (568)
Metabolic disorders (20)
Multiple sclerosis (39)
Neurodegenerative disease (69)
Neuropsychiatric disorders (39)
Neuroscience (832)
Neurotech (1)
NextGen: Class of 2026 (231)
Non-profit (219)
Now hiring (3)
Obesity (15)
Opinion (10)
Ovarian cancer (5)
Pain (14)
Pancreatic cancer (6)
Parkinson's disease (79)
Patents (18)
Patient recruitment (15)
People (2701)
Pharmaceutical (2)
Phase 1 (616)
Phase 2 (1027)
Phase 3 (1242)
Pipeline (283)
Policy (7)
Postmarket research (133)
Preclinical (393)
Prostate cancer (3)
Psychedelics (11)
Radiopharmaceuticals (6)
Rare diseases (35)
Real estate (155)
Recruiting (1)
Regulatory (711)
Research institute (240)
Resumes & cover letters (9)
Rett syndrome (5)
RNA editing (1)
RSV (1)
Schizophrenia (82)
Series A (19)
Series B (13)
Sickle cell disease (2)
Special edition (5)
Spinal muscular atrophy (35)
Sponsored (1)
Startups (146)
Supply chain (1)
Tariffs (3)
The Weekly (7)
Vaccines (12)
Venture capital (12)
Weight loss (6)
Women's health (1)
Date
Today (1)
Last 7 days (31)
Last 30 days (137)
Last 365 days (1487)
2026 (170)
2025 (1488)
2024 (1572)
2023 (1649)
2022 (1816)
2021 (2024)
2020 (1584)
2019 (1354)
2018 (1040)
2017 (1055)
2016 (1052)
2015 (1211)
2014 (862)
2013 (635)
2012 (611)
2011 (530)
2010 (459)
Location
Africa (17)
Alabama (2)
Arizona (8)
Arkansas (1)
Asia (1447)
Australia (176)
California (600)
Canada (165)
China (67)
Colorado (16)
Connecticut (56)
Delaware (6)
Europe (3460)
Florida (82)
Georgia (4)
Idaho (2)
Illinois (120)
Indiana (28)
Japan (25)
Kentucky (1)
Louisiana (1)
Maine (4)
Maryland (65)
Massachusetts (466)
Michigan (2)
Minnesota (16)
Missouri (1)
Montana (2)
Nebraska (1)
Nevada (3)
New Hampshire (3)
New Jersey (110)
New Mexico (1)
New York (217)
North Carolina (23)
Northern California (216)
Ohio (10)
Pennsylvania (92)
Puerto Rico (1)
Rhode Island (2)
South America (19)
South Carolina (1)
Southern California (327)
Tennessee (4)
Texas (31)
United States (1942)
Utah (12)
Virginia (4)
Washington D.C. (4)
Washington State (28)
Wisconsin (3)
21,000 Results for "cajal neuroscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases
Creyon Bio, Inc. (“Creyon”) and Cajal Neuroscience, (“Cajal”) today announced a partnership to develop novel OBMs for neurodegenerative diseases.
May 1, 2024
·
3 min read
Press Releases
Apollo Neuroscience Announces 2025 Year in Review
February 2, 2026
·
6 min read
Press Releases
AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam
February 2, 2026
·
3 min read
Press Releases
Klotho Neurosciences to Present at the Biotech Showcase 2026
January 8, 2026
·
2 min read
Press Releases
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 5, 2026
·
4 min read
Press Releases
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
February 1, 2026
·
7 min read
Press Releases
Cumulus Neuroscience Appoints Ricardo Sáinz Fuertes, MD as New Board Chair
January 9, 2026
·
3 min read
Press Releases
Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users
January 28, 2026
·
3 min read
BioForest
Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration
Cajal aims to accelerate neurodegeneration drug discovery by enabling target discovery and validation at unprecedented scale.
November 29, 2022
·
6 min read
Press Releases
Reunion Neuroscience Announces Program Updates and Highlights Anticipated 2026 Milestones
January 12, 2026
·
5 min read
1 of 2,100
Next
